Home COVID 19 No Antibodies Found Against Delta Variant in 16% People Fully Vaccinated With Covishield: ICMR
COVID 19Latest NewsSpotlight

No Antibodies Found Against Delta Variant in 16% People Fully Vaccinated With Covishield: ICMR

Share
Share

Amid a steady decline of daily COVID-19 cases, a new study has been recently conducted by the Indian Council of Medical Research (ICMR) which has revealed that neutralising antibodies were missing in 16% of the population who is fully vaccinated with Covishield.

According to the study, around 58% of the population who were given a single shot of the Covishield’s COVID-19 shot did not carry any of the antibodies for the newly detected Delta Variant. Covishield coronavirus vaccine is known as Oxford-AstraZeneca in other countries outside India hence the scientists are yet to conduct a study on the recipients of the Oxford-AstraZeneca’s coronavirus vaccine.

Antibodies Against Delta Variant Was Not Found

The ICMR study has revealed that the level of the neutralising antibodies titres was significantly low in those who received both the doses of Covishield’s coronavirus vaccine which couldn’t be detected.

However, the study results also added that these merely low antibodies can also provide protection against the coronavirus infection and severe disease among the vaccine recipients.

It was revealed by the experts that the count of the antibodies which mainly targets the Sars-CoV-2 viruses and destroys them before it enters the human cells were also low in these individuals.

Dr. T Jacob John, former head of the department of microbiology at Christian Medical College-Vellore was quoted as saying that,”Covishield recipients mights have some cell mediated protective immunity that can protect against infection and severe disease.”

According to the recent reports of the World Health Organisation (WHO), the deadly Delta variant of coronavirus is now present in almost 99 countries. It has been warned by the experts have also warned that the strain is on its way to become a dominant coronavirus variant worldwide.

Delta variant is a highly transmissible strain of covid-19 which was first detected in India and it is also the possible reason behind the ferocious second wave of coronavirus in the country. The variant has now mutating into another infectious strain called Delta Plus.

However, the recent emergence of B.1.617 lineage has created grave public health problem in India.

“The lineage further mutated to generate sub-lineages B.1.617.1 (Kappa), B.1.617.2 (Delta) and B.1.617.3. Apparently, the Delta variant has slowly dominated the other variants. With this, the World Health Organisation has described this sub-lineage as variant of concern,” the experts stated.

They further added, “The high transmissibility associated with Delta variant led to second wave of the pandemic in India which affected millions of people. Besides this, variant of concerns have been reported to show lower neutralisation to several approved vaccines. This has led to breakthrough infections after completion of vaccination regimen.”

 

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Latest News

How Seasonal Flu Symptoms Are Changing in 2026—and What It Means for You

Seasonal influenza, commonly known as the flu, affects millions of people worldwide every year, and 2026 has already shown changes in how the...

WHO
Press Release

WHO South-East Asia Regional Office building inaugurated

The newly constructed building of the World Health Organization South-East Asia Regional Office in New Delhi, was today inaugurated by the Honourable Prime...

Air Pollution
Health News

Delhi Chokes Under Toxic Air: Schools Shut, Offices Go Work From Home — How to Stay Safe

New Delhi, 23 December, 2025: Delhi once again finds itself gasping for breath as air pollution levels surge to hazardous levels, pushing authorities...

Colorectal cancer
Latest News

Cervical Cancer Awareness Month 2026: Screening Tips Every Woman Should Know

Cervical cancer is one of the most preventable forms of cancer, yet it remains a leading cause of cancer-related deaths among women globally....

Bird Flu
Latest News

Bird Flu Alert: How to Protect Yourself Without Panicking

Bird flu, also known as avian influenza, is a viral infection primarily affecting birds but capable of infecting humans in rare cases. The...

Section title

Related Articles
Latest News

Broken Heart Syndrome Is Real: Doctor Explains Why Emotional Stress Can Trigger Heart Attacks

When we hear the phrase “broken heart,” most of us think of...

COVID
Latest News

Long COVID May Be Triggering Alzheimer’s-Like Changes in the Brain: New Study

A new study suggests that Long COVID—the lingering post-infection condition experienced by...

Cancer
Latest News

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

Cancer treatment has evolved rapidly over the past few decades, offering patients...

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Latest News

Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity

The Nipah virus is widely regarded as one of the deadliest zoonotic...

×